Rich People Trades
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Rich People Trades

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement
next post
Editor’s Picks: Gold Price Touches US$3,500 in Volatile Week, M&A Heats Up

Related Posts

CoTec Holdings

February 14, 2025

December 2024 Quarterly Results Presentation

January 29, 2025

5 Biggest Pharmaceutical ETFs in 2025

May 7, 2025

Microbial Mining? Endolith Makes Copper Recovery Breakthrough with...

May 14, 2025

As Part of Its New Development Strategy, Cartier...

February 15, 2025

Maverick Metals Secures US$19 Million to Fast Track...

April 9, 2025

Appendix 4D and Half Yearly Accounts

February 27, 2025

4 Biggest Cybersecurity ETFs in 2025

April 29, 2025

American Salars: Building a Diversified Portfolio of Lithium...

April 11, 2025

Successful completion of Lac Carheil drilling program

April 10, 2025

CoTec Holdings

February 14, 2025

December 2024 Quarterly Results Presentation

January 29, 2025

5 Biggest Pharmaceutical ETFs in 2025

May 7, 2025

Microbial Mining? Endolith Makes Copper Recovery Breakthrough with...

May 14, 2025

As Part of Its New Development Strategy, Cartier...

February 15, 2025

Maverick Metals Secures US$19 Million to Fast Track...

April 9, 2025

Appendix 4D and Half Yearly Accounts

February 27, 2025

4 Biggest Cybersecurity ETFs in 2025

April 29, 2025

American Salars: Building a Diversified Portfolio of Lithium...

April 11, 2025

Successful completion of Lac Carheil drilling program

April 10, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      First lady Melania Trump’s new official portrait revealed

      January 28, 2025
    • 2

      Health experts prep Dem lawmakers on anti-vaccine arguments ahead of RFK Jr’s confirmation hearings

      January 28, 2025
    • 3

      Vale Launches Strategic Review of Thompson Nickel Operations Amid Market Challenges

      January 28, 2025
    • 4

      ECOWAS pledges to ‘keep door open’ after 3 coup-hit West African nations exit regional bloc

      January 30, 2025
    • 5

      American fighters are dying in Ukraine in growing numbers. Bringing their bodies home is a complex task

      January 30, 2025
    • 6

      Scorched-earth Shanahan: RFK Jr’s former running mate threatens political war against confirmation opponents

      January 30, 2025
    • 7

      Coral bleaching on Australia’s Great Barrier Reef reaches ‘catastrophic’ levels, study finds

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: richpeopletrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 richpeopletrades.com | All Rights Reserved